HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. 2017

Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
*The Kirby Institute, UNSW, Sydney, New South Wales, Australia; †Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‡Fundacion Huesped, Buenos Aires, Argentina; §University of Chile School of Medicine & Fundación Arriaran, Santiago, Chile; ‖School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; ¶Children's Hospital 2, Ho Chi Minh City, Vietnam; #Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; **University of Calgary, Calgary, Alberta, Canada; ††YRGCARE Medical Centre, Chennai, India; ‡‡Pediatric Infectious Disease Division, Escola Paulista de Medicina-Universidade Federal de SãoPaulo, São Paulo, Brazil; §§Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD; ‖‖Division of Infectious Diseases, Department of Medicine, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa; and ¶¶Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Having 90% of patients on antiretroviral therapy (ART) and achieving an undetectable viral load (VL) is 1 of the 90:90:90 by 2020 targets. In this global analysis, we investigated the proportions of adult and paediatric patients with VL suppression in the first 3 years after ART initiation. Patients from the IeDEA cohorts who initiated ART between 2010 and 2014 were included. Proportions with VL suppression (<1000 copies/mL) were estimated using (1) strict intention to treat (ITT)-loss to follow-up (LTFU) and dead patients counted as having detectable VL; and (2) modified ITT-LTFU and dead patients were excluded. Logistic regression was used to identify predictors of viral suppression at 1 year after ART initiation using modified ITT. A total of 35,561 adults from 38 sites/16 countries and 2601 children from 18 sites/6 countries were included. When comparing strict with modified ITT methods, the proportion achieving VL suppression at 3 years from ART initiation changed from 45.1% to 90.2% in adults, and 60.6% to 80.4% in children. In adults, older age, higher CD4 count pre-ART, and homosexual/bisexual HIV exposure were associated with VL suppression. In children, older age and higher CD4 percentage pre-ART showed significant associations with VL suppression. Large increases in the proportion of VL suppression in adults were observed when we excluded those who were LTFU or had died. The increases were less pronounced in children. Greater emphasis should be made to minimize LTFU and maximize patient retention in HIV-infected patients of all age groups.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072230 Sustained Virologic Response The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS. Sustained Viral Suppression,Response, Sustained Virologic,Suppression, Sustained Viral,Sustained Viral Suppressions,Sustained Virologic Responses,Virologic Response, Sustained
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
January 2018, Western Pacific surveillance and response journal : WPSAR,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
September 2023, Journal of Nepal Health Research Council,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
July 2012, JAMA,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
July 2018, Theoretical biology & medical modelling,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
March 2019, Tropical medicine & international health : TM & IH,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
August 2002, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
April 2019, Open forum infectious diseases,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
December 2020, Contemporary clinical trials communications,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
April 2016, Journal of virus eradication,
Awachana Jiamsakul, and Azar Kariminia, and Keri N Althoff, and Carina Cesar, and Claudia P Cortes, and Mary-Ann Davies, and Viet Chau Do, and Brian Eley, and John Gill, and Nagalingeswaran Kumarasamy, and Daisy Maria Machado, and Richard Moore, and Hans Prozesky, and Elizabeth Zaniewski, and Matthew Law
January 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Copied contents to your clipboard!